Global Imbalances in Funding Sources for HIV Randomized Control Trials
- PMID: 36401360
- PMCID: PMC9942170
- DOI: 10.1089/AID.2022.0068
Global Imbalances in Funding Sources for HIV Randomized Control Trials
Abstract
Improving access to grant funding is a critical aspect of strengthening research capacity outside of higher income settings, particularly in HIV/AIDS where randomized control trials (RCTs) that require substantial resources are common. In this article, we assessed recent RCTs to examine variation in how studies were funded, depending on study location and the countries where publication authors were based. We conducted a PubMed literature review to identify RCTs with HIV status or viral load endpoints published in 2019 and 2020, then analyzed cross-tabulations of funding sources by study characteristics. One hundred sixteen publications met the inclusion criteria. Research in higher income countries was most likely to be funded by biotech/pharmaceutical companies, whereas research in lower- and middle-income countries was most likely to be funded by U.S. government sources. Overall, we found the distribution of funding sources differed significantly by study and author location (χ2 = 23, p < .001). Published RCTs with HIV status or viral load endpoints are financed differently based on where studies take place and where the authors are based. As part of future research, understanding why this variation exists is critical for assessing how funding contributes to global imbalances in scientific resources.
Keywords: global health inequity; grant funding; randomized control trials; research implementation.
Conflict of interest statement
No competing financial interests exist.
Figures

Similar articles
-
Randomized controlled trials of HIV/AIDS prevention and treatment in Africa: results from the Cochrane HIV/AIDS Specialized Register.PLoS One. 2011;6(12):e28759. doi: 10.1371/journal.pone.0028759. Epub 2011 Dec 15. PLoS One. 2011. PMID: 22194905 Free PMC article.
-
Equity in global health research in the new millennium: trends in first-authorship for randomized controlled trials among low- and middle-income country researchers 1990-2013.Int J Epidemiol. 2016 Dec 1;45(6):2174-2183. doi: 10.1093/ije/dyw313. Int J Epidemiol. 2016. PMID: 28199646 Review.
-
The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.Health Policy Plan. 2018 Apr 1;33(3):335-344. doi: 10.1093/heapol/czx186. Health Policy Plan. 2018. PMID: 29309574
-
Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study.Lancet HIV. 2019 Jun;6(6):e382-e395. doi: 10.1016/S2352-3018(19)30038-4. Epub 2019 Apr 26. Lancet HIV. 2019. PMID: 31036482 Free PMC article.
-
Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countries.J Clin Epidemiol. 2017 Feb;82:29-36.e6. doi: 10.1016/j.jclinepi.2016.10.008. Epub 2016 Nov 16. J Clin Epidemiol. 2017. PMID: 27865901 Review.
References
-
- Joint United Nations Programme on HIV/AIDS: AIDS at 30: Nations at the Crossroads. Geneva: UNAIDS, 2011.
-
- Falagas ME, Bliziotis IA, Kondilis B, Soteriades ES: Eighteen years of research on AIDS: Contribution of and collaborations between different world regions. AIDS Res Hum Retroviruses 2006;22:1199–1205. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous